Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04430582
Other study ID # 00000098
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date August 4, 2020
Est. completion date April 30, 2023

Study information

Verified date February 2023
Source Joslin Diabetes Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to determine if there is a relationship between recurrent hypoglycemia (low blood sugar) and cognition (thinking) in individuals who have a history of hypoglycemia, but do not have pre-diabetes or diabetes. This study will analyze whether recurrent hypoglycemia is associated with differences in cognition (thinking), and if individuals with a history of hypoglycemia perform less well on cognitive assessments compared to individuals without known hypoglycemia.


Description:

This study will test the hypothesis that recurrent hypoglycemia is associated with differences in cognition (thinking), by analyzing results of cognitive testing in individuals with a history of hypoglycemia as compared with those without known hypoglycemia. This pilot study will identify cognitive domains of interest in participants with hypoglycemia, as well as inform the development of a future battery of assessments, which could be replicated in a larger sample. Cognitive domains which will be assessed include: memory, language, executive function, and psychomotor speed.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 80
Est. completion date April 30, 2023
Est. primary completion date April 30, 2023
Accepts healthy volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: 1. Age 18-70 years of age, inclusive, at screening. 2. Willingness to provide informed consent and attend one study visit. 3. For hypoglycemia after upper GI surgery group: Males or females diagnosed with ongoing post upper GI surgery hypoglycemia, with prior episodes of neuroglycopenia, unresponsive to dietary intervention. 4. For hypoglycemia without a history of upper gastrointestinal surgery group: Males or females diagnosed with ongoing hypoglycemia with prior episodes of neuroglycopenia, and without a history of prediabetes, diabetes, or upper GI surgery. 5. For post-bariatric without hypoglycemia group: Males or females with history of bariatric surgery, and no history of symptomatic hypoglycemia. 6. For non-surgical controls only: Males or females with no history of upper GI surgery and no history of hypoglycemia, prediabetes, or diabetes. Exclusion Criteria: 1. Active treatment with any diabetes medications, except for acarbose. 2. History of cerebrovascular accident. 3. History of a traumatic brain injury not related to hypoglycemia. 4. Active depression. 5. Active alcohol abuse or substance abuse. 6. Known insulinoma, gastrinoma or other neuroendocrine tumor. 7. Having undergone same / similar cognitive assessments within the last calendar year. There will be no involvement of special vulnerable populations such as fetuses, neonates, pregnant women, children, prisoners, institutionalized or incarcerated individuals, or others who may be considered vulnerable populations.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cognitive Assessment (not diagnostic)
Cognitive testing will assess working memory and attention, verbal memory and delayed memory, executive function, and psychomotor speed.
Diagnostic Test:
ECG
ECG will take place during screening visit.

Locations

Country Name City State
United States Joslin Diabetes Center Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Joslin Diabetes Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of verbal memory Rey Auditory Verbal Learning Test (RAVLT) immediate recall accuracy scores will be used to measure verbal memory. Scores will be compared between groups. Distributions of relevant variables will be examined for outliers and to determine appropriate statistics for use. Chi-square, Kruskal-Wallis, and analysis of variance (ANOVA) will be used to examine differences between groups. Linear models may be constructed to adjust for covariates and for effect modification. March 2025
Primary Assessment of delayed memory RAVLT 20 minute recall accuracy scores, will be used to measure delayed memory and will be compared between groups. Distributions of relevant variables will be examined for outliers and to determine appropriate statistics for use. Chi-square, Kruskal-Wallis, and analysis of variance (ANOVA) will be used to examine differences between groups. Linear models may be constructed to adjust for covariates and for effect modification. March 2025
Primary Assessment of working memory Letter-Number Sequencing subtest from the Wechsler Memory Scale III scores will be used to measure working memory and will be compared between groups. Distributions of relevant variables will be examined for outliers and to determine appropriate statistics for use. Chi-square, Kruskal-Wallis, and analysis of variance (ANOVA) will be used to examine differences between groups. Linear models may be constructed to adjust for covariates and for effect modification. March 2025
Secondary Assessment of cognitive flexibility using trail making tasks Delis-Kaplan Executive Function System (DKEFS),Trail Making Task scores will be used to assess the cognitive flexibility component of executive function. Scores are derived from time to complete the task plus errors. Distributions of relevant variables will be examined for outliers and to determine appropriate statistics for use. Chi-squared, Kruskal-Wallis, and ANOVA tests will be used to examine differences between groups. Linear models may be constructed to adjust for covariates and for effect modification. March 2025
Secondary Assessment of multitasking DKEFS Trail Making Task scores will be used to assess the multitasking component of executive function. Scores are derived from time to complete the task, plus errors. Distributions of relevant variables will be examined for outliers and to determine appropriate statistics for use. Chi-squared, Kruskal-Wallis, and ANOVA tests will be used to examine differences between groups. Linear models may be constructed to adjust for covariates and for effect modification. March 2025
Secondary Assessment of cognitive flexibility using color-word inference test DKEFS Color-Word Interference Test (CWIT) scores will be used to measure the cognitive flexibility component of executive function. The CWIT is scored by time to complete plus errors. Distributions of relevant variables will be examined for outliers and to determine appropriate statistics for use. Chi-squared, Kruskal-Wallis, and ANOVA tests will be used to examine differences between groups. Linear models may be constructed to adjust for covariates and for effect modification. March 2025
Secondary Assessment of inhibition DKEFS CWIT scores will be used to measure the inhibition component of executive function. The CWIT is scored by time to complete plus errors. Distributions of relevant variables will be examined for outliers and to determine appropriate statistics for use. Chi-squared, Kruskal-Wallis, and ANOVA tests will be used to examine differences between groups. Linear models may be constructed to adjust for covariates and for effect modification. March 2025
Secondary Assessment of verbal ability cognitive control DKEFS Verbal Fluency Task will be used to assess the verbal functioning cognitive control ability component of executive function. Scores are derived from the number of unique, correct words. Distributions of relevant variables will be examined for outliers and to determine appropriate statistics for use. Chi-squared, Kruskal-Wallis, and ANOVA tests will be used to examine differences between groups. Linear models may be constructed to adjust for covariates and for effect modification. March 2025
Secondary Assessment of psychomotor speed The Grooved Peg Board test will be used to assess psychomotor speed. It is scored according to time for completion combined with the number of dropped pegs. Distributions of relevant variables will be examined for outliers and to determine appropriate statistics for use. Chi-squared, Kruskal-Wallis, and ANOVA tests will be used to examine differences between groups. Linear models may be constructed to adjust for covariates and for effect modification. March 2025
See also
  Status Clinical Trial Phase
Completed NCT03482154 - Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population
Completed NCT03667053 - Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children Phase 3
Active, not recruiting NCT03422471 - Hypoglycemia and Autonomic Nervous System Function- B2 N/A
Recruiting NCT05379686 - Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes N/A
Completed NCT05597605 - The SHINE Study: Safety of Implant and Preliminary Performance of the SHINE SYSTEM in Diabetic Subjects N/A
Not yet recruiting NCT05990933 - Role of Adrenaline in in the Inflammatory Response in Diabetes N/A
Withdrawn NCT03736083 - Introducing CGM at Type 1 Diabetes Diagnosis N/A
Completed NCT02966275 - Post Bariatric Closed Loop Glucagon Trial N/A
Not yet recruiting NCT02909881 - Dose Response Oxidation of a Sweet-corn Derived Sugar (PhytoSpherix) During Exercise in Endurance Trained Athletes N/A
Withdrawn NCT02518022 - How to be Safe With Alcoholic Drinks in Diabetes N/A
Active, not recruiting NCT02213003 - Allogeneic Islet Cells Transplanted Onto the Omentum Phase 1/Phase 2
Completed NCT01176656 - Hypoglycemia: Physician and Patient Perspectives N/A
Completed NCT01147276 - Vildagliptin and the Glucagon Response to Hypoglycemia in Type 1 Diabetes Phase 4
Completed NCT00998374 - Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge N/A
Terminated NCT01225159 - Tight Glycaemic Control During Cardiac Surgery N/A
Completed NCT00373854 - Study of How Low Blood Sugar Affects the Way Blood Vessels Work N/A
Completed NCT00285233 - Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes Phase 1/Phase 2
Recruiting NCT05916131 - Pilot Feasibility Study for HypoPals, a Mobile Health Program for Improving Hypoglycemia Management. N/A
Terminated NCT04026750 - Insulin Tolerance Test Study in Patients With Type 1 Diabetes Phase 1
Completed NCT05133765 - The SMART B Exercise Study :''The SMART Study'' N/A